In the other studies serum FABP5 levels correlated positively with parameters of adiposity, adverse lipid profiles, serum insulin, adipocyte fatty acid binding proteins (A-FABP, FABP4), C-reactive protein levels and were higher in subjects with the metabolic syndrome (MS). Here, GOT2 is linked to myeloid sarcoma.